Results 191 to 193 of about 8,223 (193)

Comparative effectiveness of upadacitinib versus dupilumab for moderate-to-severe atopic dermatitis: A retrospective cohort study

International Immunopharmacology
Yumei Liu, Rujun Xue, Aili Gao
exaly  

Once-daily upadacitinib versus placebo in adults with extensive non-segmental vitiligo: a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-ranging study

EClinicalMedicine
Thierry Passeron, Nanja van Geel, Amit G Pandya   +2 more
exaly  

Successful treatment of refractory palmoplantar pustulosis by upadacitinib: report of 28 patients

Frontiers in Medicine
Na Du, Wei Min
exaly